Search research articles
Contact Us
Filters
Showing results (191-200 of 230) with videos related to
Page
of 23
Sort By:
Journal of Cancer Survivorship : Research and Practice
|
February 2, 2022
Pilot implementation to assess the feasibility and care team impact of an app-based interactive care plan to remotely monitor breast cancer survivors
Daniela L Stan, Jonathan W Inselman, Jennifer L Ridgeway, et al.
JCO Oncology Practice
|
June 19, 2023
Patient- and Provider-Level Factors Associated With Telehealth Utilization Across a Multisite, Multiregional Cancer Practice From 2019 to 2021
Joshua C Pritchett, Bijan J Borah, Ruchita Dholakia, et al.
JAMA Network Open
|
February 3, 2023
Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010
Carolyn M Larsen, Mariana Garcia Arango, Harika Dasari, et al.
JAMA Network Open
|
June 5, 2026
A Multiregional Decentralized Clinical Trial Program to Improve Access
Tufia C Haddad, Lydia A Mercado, Jennifer G Le-Rademacher, et al.
Mayo Clinic Proceedings
|
December 4, 2022
Impact of a High-Risk, Ambulatory COVID-19 Remote Patient Monitoring Program on Utilization, Cost, and Mortality
Tufia C Haddad, Jordan D Coffey, Yihong Deng, et al.
JCO Oncology Practice
|
June 4, 2021
Association of a Remote Patient Monitoring (RPM) Program With Reduced Hospitalizations in Cancer Patients With COVID-19
Joshua C Pritchett, Bijan J Borah, Aakash P Desai, et al.
The Oncologist
|
August 12, 2016
Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled Trial
Weidong Lu, Peter M Wayne, Roger B Davis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 13, 2018
Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors
Kathryn J Ruddy, Lindsey Sangaralingham, Rachel A Freedman, et al.
Breast Cancer Research and Treatment
|
April 14, 2021
Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance)
Tufia C Haddad, Jun He, Ciara C O'Sullivan, et al.
Cancer Immunology, Immunotherapy : CII
|
October 7, 2021
Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival
Tyler C Haddad, Songzhu Zhao, Mingjia Li, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 230) with videos related to
Sort By:
Page
of 23
Journal of Cancer Survivorship : Research and Practice
|
February 2, 2022
Pilot implementation to assess the feasibility and care team impact of an app-based interactive care plan to remotely monitor breast cancer survivors
Daniela L Stan, Jonathan W Inselman, Jennifer L Ridgeway, et al.
JCO Oncology Practice
|
June 19, 2023
Patient- and Provider-Level Factors Associated With Telehealth Utilization Across a Multisite, Multiregional Cancer Practice From 2019 to 2021
Joshua C Pritchett, Bijan J Borah, Ruchita Dholakia, et al.
JAMA Network Open
|
February 3, 2023
Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010
Carolyn M Larsen, Mariana Garcia Arango, Harika Dasari, et al.
JAMA Network Open
|
June 5, 2026
A Multiregional Decentralized Clinical Trial Program to Improve Access
Tufia C Haddad, Lydia A Mercado, Jennifer G Le-Rademacher, et al.
Mayo Clinic Proceedings
|
December 4, 2022
Impact of a High-Risk, Ambulatory COVID-19 Remote Patient Monitoring Program on Utilization, Cost, and Mortality
Tufia C Haddad, Jordan D Coffey, Yihong Deng, et al.
JCO Oncology Practice
|
June 4, 2021
Association of a Remote Patient Monitoring (RPM) Program With Reduced Hospitalizations in Cancer Patients With COVID-19
Joshua C Pritchett, Bijan J Borah, Aakash P Desai, et al.
The Oncologist
|
August 12, 2016
Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled Trial
Weidong Lu, Peter M Wayne, Roger B Davis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 13, 2018
Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors
Kathryn J Ruddy, Lindsey Sangaralingham, Rachel A Freedman, et al.
Breast Cancer Research and Treatment
|
April 14, 2021
Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance)
Tufia C Haddad, Jun He, Ciara C O'Sullivan, et al.
Cancer Immunology, Immunotherapy : CII
|
October 7, 2021
Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival
Tyler C Haddad, Songzhu Zhao, Mingjia Li, et al.
Page
of 23